SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-006035
Filing Date
2023-10-04
Accepted
2023-10-04 07:00:09
Documents
8
Period of Report
2023-10-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_100323.htm 6-K 9635
2 EXHIBIT 99.1 exh_991.htm EX-99.1 6153
3 EXHIBIT 99.2 exh_992.htm EX-99.2 64547
4 EXHIBIT 99.3 exh_993.htm EX-99.3 968
5 GRAPHIC logo.jpg GRAPHIC 13527
6 GRAPHIC exh993_1.jpg GRAPHIC 243829
7 GRAPHIC exh993_2.jpg GRAPHIC 239633
8 GRAPHIC logo_small.jpg GRAPHIC 8776
  Complete submission text file 0001171843-23-006035.txt   778795
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 231306556
SIC: 2834 Pharmaceutical Preparations